Skip to main content
Erschienen in: International Urogynecology Journal 10/2018

21.02.2018 | Original Article

Pubovesical sling for residual incontinence after successful vesicovaginal fistula closure: a new approach to an old procedure

verfasst von: Sunday Lengmang, Steven Shephard, Avisek Datta, Svjetlana Lozo, Carolyn V. Kirschner

Erschienen in: International Urogynecology Journal | Ausgabe 10/2018

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

For decades, the pubovesical (PV) sling has been in the armamentarium of the fistula surgeon for treating persistent urinary incontinence after successful fistula closure. We report our early experience with slings, and then also introduce a new “tight” PV sling technique for management of post-fistula urethral leak. Our hypothesis is that performance of tight slings might result in improved continence for women with persistent urinary incontinence after obstetric fistula closure.

Methods

Data from 120 patients in whom some type of sling procedure had been performed between 1996 and 2012 were extracted and labeled as “early slings.” Beginning in October 2014, more complete data were recorded and a more uniform approach was undertaken in 40 patients. Data were extracted from their charts and recorded as “tight slings.” This information was analyzed using Chi-squared analysis.

Results

Tight slings were more successful in patients who had less severe fibrosis and who had a shorter time since initial injury. Thirty percent of women who underwent tight slings had improved continence at follow-up.

Conclusion

Persistent urinary incontinence despite successful surgical closure of obstetrical fistula remains a difficult problem. Tight slings may be warranted in an attempt to avoid urinary diversion.
Literatur
1.
Zurück zum Zitat Kirschner CV, Yost KJ, Du H, et al. Obstetric fistula: the ECWA evangel VVF center surgical experience from Jos, Nigeria. Int Urogynecol J. 2010;21:1525–33.CrossRefPubMedCentral Kirschner CV, Yost KJ, Du H, et al. Obstetric fistula: the ECWA evangel VVF center surgical experience from Jos, Nigeria. Int Urogynecol J. 2010;21:1525–33.CrossRefPubMedCentral
2.
Zurück zum Zitat Browning A. Risk factors for developing residual urinary incontinence after obstetric fistula repair. BJOG. 2006;113:482–5.CrossRefPubMedCentral Browning A. Risk factors for developing residual urinary incontinence after obstetric fistula repair. BJOG. 2006;113:482–5.CrossRefPubMedCentral
3.
Zurück zum Zitat Goh J, Browning A, Berhan B, Chang A. Predicting the risk of failure of closure of obstetric fistula and residual urinary incontinence using a classification system. Int Urogynecol J. 2008;19:1659–62.CrossRef Goh J, Browning A, Berhan B, Chang A. Predicting the risk of failure of closure of obstetric fistula and residual urinary incontinence using a classification system. Int Urogynecol J. 2008;19:1659–62.CrossRef
4.
Zurück zum Zitat Kirschner CV, Lengmang S, Zhou Y, Chima GAA, Karshima JA, Arrowsmith S. Urinary diversion for patients with inoperable obstetric vesicovaginal fistula: the Jos, Nigeria experience. Int Urogynecol J. 2016;27:865–70.CrossRefPubMedCentral Kirschner CV, Lengmang S, Zhou Y, Chima GAA, Karshima JA, Arrowsmith S. Urinary diversion for patients with inoperable obstetric vesicovaginal fistula: the Jos, Nigeria experience. Int Urogynecol J. 2016;27:865–70.CrossRefPubMedCentral
5.
Zurück zum Zitat Gutman RE, Dodson JL, Mostwin JL. Complications of treatment of obstetric fistula in the developing world: gynatresia, urinary incontinence, and urinary diversion. Int J Gynaecol Obstet. 2007;99(Suppl 1):S57–64.CrossRefPubMedCentral Gutman RE, Dodson JL, Mostwin JL. Complications of treatment of obstetric fistula in the developing world: gynatresia, urinary incontinence, and urinary diversion. Int J Gynaecol Obstet. 2007;99(Suppl 1):S57–64.CrossRefPubMedCentral
6.
Zurück zum Zitat Browning A. The problem of continuing urinary incontinence after obstetric vesicovaginal surgery. Obstetric fistula in developing countries. London: RCOG International News; 2012. http://www. rcog. org. uk/book/problem-continuing-urinary-incontinence-after-obstetric-vesicovaginal-surgery Google Scholar Browning A. The problem of continuing urinary incontinence after obstetric vesicovaginal surgery. Obstetric fistula in developing countries. London: RCOG International News; 2012. http://​www.​ rcog. org. uk/book/problem-continuing-urinary-incontinence-after-obstetric-vesicovaginal-surgery Google Scholar
7.
Zurück zum Zitat Goh JT, Krause H, Tessema AB, Abraha G. Urinary symptoms and urodynamics following obstetric genitourinary fistula repair. Int Urogynecol J. 2013;24:947–51.CrossRefPubMedCentral Goh JT, Krause H, Tessema AB, Abraha G. Urinary symptoms and urodynamics following obstetric genitourinary fistula repair. Int Urogynecol J. 2013;24:947–51.CrossRefPubMedCentral
8.
Zurück zum Zitat Castille Y, Avocetien C, Zaongo D, Colas J, Peabody J, Rochat C. One-year follow-up of women who participated in a physiotherapy and health education program before and after obstetric fistula surgery. Int J Gynecol Obstet. 2015;128:264–6.CrossRef Castille Y, Avocetien C, Zaongo D, Colas J, Peabody J, Rochat C. One-year follow-up of women who participated in a physiotherapy and health education program before and after obstetric fistula surgery. Int J Gynecol Obstet. 2015;128:264–6.CrossRef
Metadaten
Titel
Pubovesical sling for residual incontinence after successful vesicovaginal fistula closure: a new approach to an old procedure
verfasst von
Sunday Lengmang
Steven Shephard
Avisek Datta
Svjetlana Lozo
Carolyn V. Kirschner
Publikationsdatum
21.02.2018
Verlag
Springer London
Erschienen in
International Urogynecology Journal / Ausgabe 10/2018
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-018-3582-x

Weitere Artikel der Ausgabe 10/2018

International Urogynecology Journal 10/2018 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.